Home > Health & Beauty

Health & Beauty

Mesothelioma Cancer Cardio AIDS
Alternative Medicine Biotechnology Clinical Trials
Dental Diabetes FDA
Fitness & Nutrition Genetics Hospitals
Infectious Diseases Medical Devices Medical Supplies
Mental Health Nursing Oncology
Optical Pharmaceutical Radiology
Veterinary
October 23, 2014 11:10
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: ContextVision (OSE:COV) continued its stable sales development in the third quarter 2014 and saw a five per cent sales growth after the first nine months. The Company reached several milestones in broadening its technology and product offering. Context...
World  World      Medical Devices  Medical Devices
October 23, 2014 10:50
HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: The shareholders in Medivir AB (STO:MVIR-B) are hereby summoned to the extraordinary general meeting on Thursday 20 November 2014 at 10 a.m. at the conference center Nio Rum, Hamngatan 2, Stockholm, Sweden. Participation Shareholders who wish to...
World  World      Pharmaceutical  Pharmaceutical
October 23, 2014 10:49
LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent (STO:BINV) : Third quarter 2014, July – September · Net sales for July – September 2014 amounted to SEK 11 (7.8) million. · Earnings after tax for July – September 2014: SEK -10 (-15) million. · Earnings after tax per share for July – Sept...
World  World      Oncology  Oncology
October 23, 2014 10:00
LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH (Paris:ERYP)(Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, announces today the suc...
World  World      Biotechnology  Biotechnology
October 23, 2014 10:00
LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP)(Euronext Paris : FR0011471135 - ERYP), la société biopharmaceutique française qui développe des traitements innovants qui affament les tumeurs dans les leucémies aiguës et d'autres indications oncologiques ayant des besoi...
World  World      Biotechnology  Biotechnology
October 23, 2014 08:55
NEWARK, Calif.--(BUSINESS WIRE)--According to a new report by RMS, the world’s leading catastrophe risk management firm, the Ebola virus disease outbreak in West Africa has the potential to be the most deadly infectious disease event since the 1918 flu pandemic. The current outbreak will continue...
World  World      Hospitals  Hospitals